Smith Group Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-14,680
Closed -$878K 436
2018
Q2
$878K Buy
14,680
+310
+2% +$16.7K 0.03% 180
2018
Q1
$580K Sell
14,370
-12,000
-46% -$585K 0.02% 192
2017
Q4
$1.39M Buy
26,370
+2,530
+11% +$135K 0.04% 158
2017
Q3
$1.12M Sell
23,840
-100
-0.4% -$4.03K 0.04% 166
2017
Q2
$847K Buy
23,940
+4,620
+24% +$143K 0.03% 173
2017
Q1
$456K Sell
19,320
-20
-0.1% -$396 0.01% 192
2016
Q4
$258K Hold
19,340
0.01% 232
2016
Q3
$359K Hold
19,340
0.01% 206
2016
Q2
$237K Buy
+19,340
New +$146K 0.01% 234

Other funds holding EXAS

Smith Group Asset Management's EXAS Position: Q3 2018 in Review

Smith Group Asset Management sold out of Exact Sciences (EXAS) in Q3 2018, closing a stake of 14,680 shares — an estimated $878K sold.

Smith Group Asset Management first reported a position in EXAS in Q2 2016 and held it in 9 quarters. The position peaked at $1.39M in Q4 2017. 365 funds tracked by Wall St. Rank hold EXAS as of Q3 2018.

  • Smith Group Asset Management reported no remaining Exact Sciences position as of Q3 2018 after selling out during the quarter.
  • Smith Group Asset Management sold 14,680 Exact Sciences shares in Q3 2018, an estimated $878K.
  • Smith Group Asset Management first reported a position in Exact Sciences in Q2 2016 and held it in 9 quarters.
  • Smith Group Asset Management's Exact Sciences position peaked at $1.39M in Q4 2017.
  • 365 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2018.

Based on Smith Group Asset Management's 13F filing for Q3 2018, filed 2 Nov 2018.